Alexander Roberto Precioso

Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults

Esper G. Kallás, Monica A T Cintra, J. A. A. Moreira et al. · New England Journal of Medicine · 2024 · 152 citations · Full text

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases

Carla Gonçalves Schahin Saad, Eduardo Ferreira Borba, Nádia Emi Aikawa et al. · Annals of the Rheumatic Diseases · 2011 · 103 citations

Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial

Esper G. Kallás, Alexander Roberto Precioso, Ricardo Palácios et al. · The Lancet Infectious Diseases · 2020 · 100 citations

Vaccination, Vaccine Safety, Placebo-controlled Phase 2 +4

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice

Ana Cristina de Medeiros Ribeiro, Lissiane Karine Noronha Guedes, Júlio César Bertacini de Moraes et al. · Annals of the Rheumatic Diseases · 2011 · 96 citations

Immune correlates of protection for dengue: State of the art and research agenda

Leah C. Katzelnick, Eva Harris, Ralph S. Baric et al. · Vaccine · 2017 · 95 citations

Vaccination, Research Agenda, Humoral Response +8